DPP4 and COVID-19: Since DPP-4 in the circulation degrades GLP-1 rapidly to maintain glucose homeostasis, the use of DPP-4is may promote the anti-inflammatory effect of GLP-1 and indirectly achieve the purpose of inhibiting inflammation in patients with COVID-19.